Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-11
2005-01-11
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06841564
ABSTRACT:
Novel ethanes substituted with i) a phenyl, ii) a thiazole, and iii) a pyridyl moiety are PDE4 inhibitors.
REFERENCES:
patent: 5340827 (1994-08-01), Beeley et al.
patent: 5491147 (1996-02-01), Boyd et al.
patent: 5608070 (1997-03-01), Alexander et al.
patent: 5622977 (1997-04-01), Warrellow et al.
patent: 5633257 (1997-05-01), Warrellow et al.
patent: 5679712 (1997-10-01), Schwark et al.
patent: 5693672 (1997-12-01), Weichert et al.
patent: 5710160 (1998-01-01), Guay et al.
patent: 5710170 (1998-01-01), Guay et al.
patent: 5736297 (1998-04-01), Roeschert et al.
patent: 5739144 (1998-04-01), Warrellow et al.
patent: 5747541 (1998-05-01), Weichert et al.
patent: 5776958 (1998-07-01), Warrellow et al.
patent: 5780477 (1998-07-01), Head et al.
patent: 5780478 (1998-07-01), Alexander et al.
patent: 5786354 (1998-07-01), Warrellow et al.
patent: 5798373 (1998-08-01), Warrellow
patent: 5849770 (1998-12-01), Head et al.
patent: 5859034 (1999-01-01), Warrellow et al.
patent: 5866593 (1999-02-01), Warrellow et al.
patent: 5891896 (1999-04-01), Warrellow et al.
patent: 6399636 (2002-06-01), Freisen et al.
patent: 811610 (1997-12-01), None
patent: WO 9422852 (1994-10-01), None
patent: WO 9535283 (1995-12-01), None
patent: WO 9600215 (1996-01-01), None
patent: WO 9825883 (1998-06-01), None
patent: WO 9950262 (1999-10-01), None
Ken-ici Miyamoto et al.,Biochem. Pharmacology, 54:613-617(1997).
C. Burnouf, et al.,Ann. Rep. In Med. Chem., 33:91-109(1998).
B. Hughes, et al.,Br. J. Pharmacol., 118:1183-1191(1996).
M.J. Perry, et al.,Cell Biochem Biophys., 29:113-132(1998).
S.B. Christensen, et al.,J. Med. Chem., 44:821-835(1998).
M.D. Houslay, et al.,Adv. in Pharmacol., 44:225-342(1998).
D. Spina, et al.,Adv. in Pharmacol., 44:33-89(1998).
Blouin Marc
Cote Bernard
Ducharme Yves
Freisen Richard
Frenette Richard
Dentz Bernard
Merck Frosst Canada & Co.
Panzer Curtis C.
Rose David L.
LandOfFree
Tri-aryl-substituted-ethane PDE4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tri-aryl-substituted-ethane PDE4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tri-aryl-substituted-ethane PDE4 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3387015